QUAKER CHEMICAL CORP — Form 8-K
Filed October 29, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 45/100
What the filing says
Quaker Houghton reported Q3 2026 net sales of $544.5M (+10% YoY) driven by 7% pricing/mix and 3% volume growth from new business wins across all segments. Non-GAAP EPS was $2.39 (+15% YoY); adjusted EBITDA was $89.8M (+8% YoY, second consecutive quarterly record). Nine-month 2026 net income was $76.5M (vs. loss of $23.2M in 9M 2025); operating cash flow was $47.6M vs. $89.9M prior year, reflecting higher working capital outflows. As of Sept 30, gross debt $894.6M, cash $167M, net debt $727.6M (leverage 2.3x). No M&A, financing, or material operational changes disclosed; company repurchased 21,781 shares for $3.3M in Q3.
Why this rating
Solid earnings beat and record EBITDA mark genuine operational progress. At $1.5B market cap, $50.7M sequential sales growth (3.4% of annual run rate) and improved profitability matter but are normal execution, not transformational. Leverage stable; no debt or covenant concerns. Positive but routine quarterly performance.
See more from October 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.